M&A Deal Summary

Inovie Acquires Biofutur

On December 9, 2021, Inovie acquired life science company Biofutur from Omnes Capital

Acquisition Highlights
  • This is Inovie’s 1st transaction in the Life Science sector.
  • This is Inovie’s 1st transaction in France.

M&A Deal Summary
Date 2021-12-09
Target Biofutur
Sector Life Science
Buyer(s) Inovie
Sellers(s) Omnes Capital
Deal Type Add-on Acquisition

Target

Biofutur

L'Isle-Adam, France
Biofutur is a group of medical biology analysis laboratories, managed by independent medical biologists. The Biofutur group wishes to continue its development thanks, among other things, to the quality of its local medical care and its patient service. Biofutur is based in L'Isle-Adam, France.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Inovie

Montpellier, France
Category Company
Founded 2010
Sector Healthcare Services
Employees4,500
DESCRIPTION

Inovie is a medical diagnostic provider in France and a key player across Southern and Central France specifically. Inovie with a strong local footprint of 19 multi-site laboratories spread over five key regions (Occitanie, Provence-Alpes-Côte-d’Azur, Nouvelle Aquitaine Auvergne Rhône Alpes, and Centre Val de Loire), Inovie’s biologists and employees deliver high-standard clinical pathology testing to more than 46,000 patients daily. Inovie has also played a role in innovation, notably through their work in four areas of specialty: fertility (Inovie Fertilité), genomics (Imagenome), anatomy pathology (Inopath), and veterinary services (Inovie Vet). Inovie Group was founded in 2010 and is based in Montpellier, France.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (France) 1 of 1
Year (2021) 1 of 1

Seller(S) 1

SELLER

Omnes Capital

Paris, France

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2004
PE ASSETS 5.7B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Omnes Capital formerly known as Credit Agricole Private Equity (CAPE) is the investment arm of financial services group Credit Agricole. Omnes Capital looks to invest in a range of investment stages and transaction types, including LBO/expansion, venture capital, mezzanine, renewable energy, co-investment, infrastructure, and special situations. The Firm's LBO/expansion group looks to invest €25 to €80 million to support growth initiatives and buyouts of small and mid-cap businesses operating in a variety of industries. Omnes Capital generally invests in businesses operating in France and Italy. Omnes Capital's mezzanine area was formed in 2002 and looks to provide €5 to €30 million of junior capital to similar sized established businesses. In addition to Omnes Capital's traditional equity and subordinated debt investment arm, the Firm also invests in infrastructure projects as well as provides capital for distressed businesses with €10 to €150 million in revenue. Omnes Capital was formed in 2004 and is based in Paris.

DEAL STATS #
Overall 104 of 115
Sector (Life Science) 5 of 6
Type (Add-on Acquisition) 47 of 52
Country (France) 82 of 88
Year (2021) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-02 Ortus

Milano, Italy

Ortus was formed to acquire and to advance completion of renewable energy projects. Ortus’ portfolio is comprised of several hundred MW of onshore wind and solar PV projects at various stages of development. Ortus is based in Milano, Italy.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-13 Ikaros Solar

Schoten, Belgium

Ikaros Solar develops, builds, owns and operates photovoltaic solar power plants in roof and ground. Ikaros Solar was founded in 2006 and is based in Schoten, Belgium.

Sell -
Mergr

Product

Company

Legal